Policy brief shows support for antibiotic development incentives
Interviews with policymakers and antimicrobial resistance (AMR) experts from 13 countries indicate broad support for financial incentives to boost antibiotic development, despite uncertainty over which incentives are appropriate and how much they ll cost, according to a policy brief released yesterday by the European Union Joint Action Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI) and the Global AMR Research and Development Hub.
In the interviews, which were conducted to better understand perceptions of antibiotic development incentives and barriers to implementing them, 11 of 13 interviewees expressed high-level, general support for incentive programs. But before selecting a type of incentive, they said they prefer to wait for evidence from the three countries United Kingdom, Germany, and Sweden currently testing pull incentives models that aim to increase revenues for antibiotics whil